Developing a new class of engineered live bacterial therapeutics to treat human diseases.
Saved in:
| Title: | Developing a new class of engineered live bacterial therapeutics to treat human diseases. |
|---|---|
| Authors: | Charbonneau MR; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA., Isabella VM; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA., Li N; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA., Kurtz CB; Synlogic, Inc., 301 Binney Street, Cambridge, MA, 02142, USA. caroline@synlogictx.com. |
| Source: | Nature communications [Nat Commun] 2020 Apr 08; Vol. 11 (1), pp. 1738. Date of Electronic Publication: 2020 Apr 08. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-020-15508-1 |
